Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cytokeratin 19 Antikörper (AA 285-298)

Verified KRT19 Reaktivität: Human WB, IHC, ELISA Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN1781975
  • Target Alle Cytokeratin 19 (KRT19) Antikörper anzeigen
    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
    Bindungsspezifität
    • 21
    • 16
    • 16
    • 11
    • 8
    • 8
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 285-298
    Reaktivität
    • 270
    • 95
    • 76
    • 7
    • 7
    • 6
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 142
    • 136
    • 2
    • 2
    • 1
    Ziege
    Klonalität
    • 145
    • 138
    Polyklonal
    Konjugat
    • 124
    • 32
    • 20
    • 13
    • 7
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Dieser Cytokeratin 19 Antikörper ist unkonjugiert
    Applikation
    • 192
    • 96
    • 85
    • 80
    • 68
    • 45
    • 41
    • 39
    • 33
    • 31
    • 22
    • 22
    • 7
    • 6
    • 6
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    Verwendungszweck
    cytokeratin 19 (aa285-298)
    Sequenz
    HTEQLQMSRS EVTD
    Kreuzreaktivität
    Human
    Aufreinigung
    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
    Güteklasse
    Verified
    Isotyp
    IgG
    Top Product
    Discover our top product KRT19 Primärantikörper
  • Applikationshinweise

    Immunohistochemistry: Paraffin embedded Human Liver. Recommended concentration: 2.5 μg/mL.

    Western Blot: Approx 43 kDa band observed in Human cancer lysates of Breast, Pancreas and Colon (calculated MW of 44.1 kDa according to NP_002267.2). Recommended concentration: 0.03-0.1 μg/mL. Primary incubation was 1 hour.

    Peptide ELISA: antibody detection limit dilution 1:128000.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Minimize freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
  • Target
    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
    Andere Bezeichnung
    KRT19 (KRT19 Produkte)
    Synonyme
    CK19 antikoerper, K19 antikoerper, K1CS antikoerper, AI663979 antikoerper, EndoC antikoerper, Krt-1.19 antikoerper, Krt1-19 antikoerper, Ka19 antikoerper, k19 antikoerper, ck19 antikoerper, k1cs antikoerper, krt9 antikoerper, krt15 antikoerper, MGC76282 antikoerper, GK-19 antikoerper, MGC83069 antikoerper, KRT19 antikoerper, keratin 19 antikoerper, keratin 19 L homeolog antikoerper, keratin, type I cytoskeletal 19 antikoerper, KRT19 antikoerper, Krt19 antikoerper, krt19 antikoerper, krt19.L antikoerper, LOC100344434 antikoerper, LOC101117946 antikoerper
    Hintergrund
    KRT19, keratin 19, CK19, K19, K1CS, 40- kDa keratin intermediate filament, CK-19, cytokeratin 19, cytokeratin-19, keratin, type I cytoskeletal 19, keratin, type I, 40-kd, keratin-19
    Molekulargewicht
    Expected molecular weight: 43 kDa
    Gen-ID
    3880
    NCBI Accession
    NP_002267
Sie sind hier:
Kundenservice